Welcome to the latest edition of “This Week in Policy and Medicine,” your go-to resource for the significant developments in healthcare policy, life science regulations, and medical education insights. In addition to this summary, catch up on our comprehensive coverage and listen to our podcast for deeper discussions on these topics, available on Spotify and other podcast platforms.
President Trump Establishes “Make America Healthy Again” Commission
President Trump has announced the formation of the “Make America Healthy Again” Commission, aimed at enhancing national health policies and their implications on life sciences and continuing healthcare education. The commission seeks to streamline regulatory processes and foster innovation in healthcare research and practice. Read more about the implications for life science journal publications and continuing healthcare education.
United States Sues Walgreens Over Violations of the Controlled Substances Act and False Claims Act
The U.S. government has filed a lawsuit against Walgreens, accusing the pharmacy giant of violating the Controlled Substances Act and the False Claims Act. This legal action highlights the ongoing challenges in pharmaceutical practices and underscores the need for stringent compliance measures within the industry. Explore the details of the case.
DOJ Sues CVS Alleging Violations of the Controlled Substances Act
Following similar allegations as those against Walgreens, the Department of Justice has also taken legal action against CVS. The lawsuit addresses significant non-compliance with the Controlled Substances Act, focusing on CVS’s role in the opioid crisis. Read more about the lawsuit and its implications.
NIH Issues New Public Access Policy for NIH-funded Research
The National Institutes of Health has updated its public access policy for NIH-funded research. The new guidelines aim to improve the dissemination and accessibility of research findings to the public and the scientific community, fostering a more open exchange of knowledge. Learn more about the new policy.
White Paper Released on AI for Clinical Research Professionals
A new white paper on the use of artificial intelligence (AI) in clinical research has been released, detailing the latest advancements and the potential of AI to transform clinical trials and healthcare outcomes. This document serves as a crucial resource for professionals navigating the intersection of AI and clinical research. Read the white paper.
Listen to Our Podcast
For more in-depth analysis and expert commentary on these stories, tune in to “This Week in Policy and Medicine” on Spotify or your favorite podcast platforms.